It would be interesting to consider the direct effect of low-dose IL-2 on glucose metabolism and whether engineering of IL-2 to improve its action will ameliorate diabetes and its complications, including diabetic retinopathy [50]. This evidence concerns the gene IL2 and diabetic retinopathy.